Skip to main content
Log in

Kutane Vaskulitis und Vaskulopathie

Differenzialdiagnosen an der unteren Extremität

Cutaneous vasculitis and vasculopathy

Differential diagnosis in biopsies of the lower extremities

  • Schwerpunkt: Diagnose entzündlicher Dermatosen
  • Published:
Der Pathologe Aims and scope Submit manuscript

Zusammenfassung

Die Haut zählt zu den häufigsten Manifestationsorten systemischer primärer und sekundärer Vaskulitiden. Ferner tritt eine Vaskulitis nicht selten rein kutan als Einzelorganvaskulitis auf. Prädilektionsorte sind die unteren Extremitäten mit den Leitsymptomen palpable Purpura, Knoten und Ulzera. Grundlage der histopathologischen Diagnostik ist die korrekte Einordnung des befallenen Gefäßtyps und die sichere Identifizierung einer Gefäßschädigung bei der Vaskulitis in Abgrenzung zu unspezifischen reaktiven Gefäßveränderungen, vaskulär okklusiven Erkrankungen, nichtinflammatorischer Purpura und perivaskulären Infiltraten infolge entzündlicher Dermatosen. Die Mehrzahl kutaner Vaskulitiden sind Kleingefäßvaskulitiden. Diese weisen im floriden Stadium unabhängig von der Ätiologie meist das Bild einer dermalen leukozytoklastischen Vaskulitis auf. Zusätzliche extravaskuläre Veränderungen können eine weitere Einordnung erlauben, in der Regel ist jedoch eine Korrelation mit Klinik, Bildgebung und Serologie erforderlich. Entscheidend für die Diagnose ist auch die Entnahmetechnik der Biopsie unter Berücksichtigung des klinisch vermuteten Gefäßbefalls. Gerade bei Ulzera ist ein ausreichender Saum umgebender Haut und Subkutis diagnostisch unerlässlich. Für die Diagnose einer Polyarteriitis nodosa und nodulärer Vaskulitis ist die Beurteilung der Subkutis erforderlich. Eine Großgefäßvaskulitis kommt in Hautbiopsien der unteren Extremität nicht vor.

Abstract

The skin is one of the most frequently involved organs in primary systemic and secondary vasculitis; moreover, a vasculitis can occur as single organ vasculitis, limited to the skin. For most types of vasculitis, the lower extremities constitute common sites with clinical symptoms of palpable purpura, nodules, and ulcers. In histopathology of cutaneous vasculitis, it is of utmost importance to correctly identify the vessel types involved and to discriminate between vasculitic vessel damage, unspecific reactive vessel changes, vascular occlusive diseases, noninflammatory purpura, or perivascular infiltrates due to other inflammatory skin diseases. Small-vessel vasculitis is the most frequent type of cutaneous vasculitis; during florid phases, a dermal leukocytoclastic vasculitis is found regardless of etiology. Additional extravascular changes may give etiological clues, however, a correlation with the clinical picture, radiology, and serology is essential. The biopsy type and technique need to be adjusted to the suspected diagnosis and site of the vessels involved. Polyarteritis nodosa and nodular vasculitis can be diagnosed only in biopsies with sufficient subcutaneous tissue. Especially in cutaneous ulcers, a lateral rim of vital skin and subcutaneous tissue is indispensable for a correct diagnosis. Large-vessel vasculitis is not found in skin biopsies of the lower extremities.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1
Abb. 2
Abb. 3
Abb. 4
Abb. 5
Abb. 6

Literatur

  1. Buffiere-Morgado A, Battistella M, Vignon-Pennamen MD et al (2015) Relationship between cutaneous polyarteritis nodosa (cPAN) and macular lymphocytic arteritis (MLA): blinded histologic assessment of 35 cPAN cases. J Am Acad Dermatol 73:1013–1020

    Article  Google Scholar 

  2. Carlson JA (2010) The histological assessment of cutaneous vasculitis. Histopathology 56:3–23

    Article  Google Scholar 

  3. Carlson JA, Chen KR (2006) Cutaneous vasculitis update: small vessel neutrophilic vasculitis syndromes. Am J Dermatopathol 28:486–506

    Article  Google Scholar 

  4. Carlson JA, Chen KR (2007) Cutaneous vasculitis update: neutrophilicmuscular vessel and eosinophilic, granulomatous, and lymphocytic vasculitis syndromes. Am J Dermatopathol 29:32–43

    Article  Google Scholar 

  5. Carlson JA, Ng BT, Chen KR (2005) Cutaneous vasculitis update: diagnostic criteria, classification, epidemiology, etiology, pathogenesis, evaluation and prognosis. Am J Dermatopathol 27:504–528

    Article  Google Scholar 

  6. Chen KR (2010) The misdiagnosis of superficial thrombophlebitis as cutaneous polyarteritis nodosa: features of the internal elastic lamina and the compact concentric muscular layer as diagnostic pitfalls. Am J Dermatopathol 32:688–693

    Article  Google Scholar 

  7. Chen KR, Toyohara A, Suzuki A et al (2002) Clinical and histopathological spectrum of cutaneous vasculitis in rheumatoid arthritis. Br J Dermatol 147:905–913

    Article  Google Scholar 

  8. Criado PR, Marques GF, Morita TC et al (2016) Epidemiological, clinical and laboratory profiles of cutaneous polyarteritis nodosa patients: report of 22 cases and literature review. Autoimmun Rev 15:558–563

    Article  Google Scholar 

  9. Cribier B, Couilliet D, Meyer P, Grosshans E (1999) The severity of histopathological changes of leukocytoclastic vasculitis is not predictive of extracutaneous involvement. Am J Dermatopathol 21:532–536

    Article  CAS  Google Scholar 

  10. Fain O, Hamidou M, Cacoub P et al (2007) Vasculitides associated with malignancies: analysis of sixty patients. Arthritis Rheum 57:1473–1480

    Article  Google Scholar 

  11. Gonzalez CD, Florell SR, Bowen AR (2019) Histopathologic vasculitis from the periulcer edge: a retrospective cohort study. J Am Acad Dermatol 81:1353–1357

    Article  Google Scholar 

  12. Gota CE, Calabrese LH (2013) Diagnosis and treatment of cutaneous leukocytoclastic vasculitis. Int J Clin Rheumatol 8:49–60

    Article  CAS  Google Scholar 

  13. Guillevin L, Mahr A, Callard P, Godmer P, Pagnoux C, Leray E, Cohen P, French Vasculitis Study Group (2005) Hepatitis B virus-associated polyarteritis nodosa: clinical characteristics, outcome, and impact of treatment in 115 patients. Medicine (Baltimore) 84:313–322

    Article  Google Scholar 

  14. Hafner J, Nobbe S, Läuchli S et al (2014) Ulcus hypertonicum Martorell. Schweiz Med Forum 12:242–245

    Google Scholar 

  15. Hasler P, Kistler H, Gerber H (1995) Vasculitides in hairy cell leukemia. Semin Arthritis Rheum 25:134–142

    Article  CAS  Google Scholar 

  16. Jennette JC, Falk RJ, Bacon PA et al (2013) 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum 65:1–11

    Article  CAS  Google Scholar 

  17. Lath K, Chatterjee D, Saikia UN et al (2018) Role of direct immunofluorescence in cutaneous small-vessel vasculitis: experience from a tertiary center. Am J Dermatopathol 40:661–666

    Article  Google Scholar 

  18. Kelly RI, Wee E, Balta S, Williams RA (2020) Lymphocytic thrombophilic arteritis and cutaneous polyarteritis nodosa: clinicopathologic comparison with blinded histologic assessment. J Am Acad Dermatol. https://doi.org/10.1016/j.jaad.2019.10.068

    Article  PubMed  Google Scholar 

  19. Llamas-Velasco M, Alegría V, Santos-Briz Á et al (2017) Occlusive nonvasculitic vasculopathy. Am J Dermatopathol 39:637–662

    Article  Google Scholar 

  20. Mimouni D, Ng PP, Rencic A, Nikolskaia OV et al (2003) Cutaneous polyarteritis nodosa in patients presenting with atrophie blanche. Br J Dermatol 148:789–794

    Article  CAS  Google Scholar 

  21. Pagnoux C, Seror R, Henegar C, Mahr A, Cohen P, Le Guern V, Bienvenu B, Mouthon L, Guillevin L, French Vasculitis Study Group (2010) Clinical features and outcomes in 348 patients with polyarteritis nodosa: a systematic retrospective study of patients diagnosed between 1963 and 2005 and entered into the French Vasculitis Study Group Database. Arthritis Rheum 62:616–626

    Article  Google Scholar 

  22. Pendergraft WF III, Niles JL (2014) Trojan horses: drug culprits associated with antineutrophil cytoplasmic autoantibody (ANCA) vasculitis. Curr Opin Rheumatol 26:42–49

    Article  CAS  Google Scholar 

  23. Ramos-Casals M, Stone JH, Cid MC (2012) The cryoglobulinaemias. Lancet 379:348–360

    Article  CAS  Google Scholar 

  24. Ramos-Casals M, Nardi N, Lagrutta M et al (2006) Vasculitis in systemic lupus erythematosus: prevalence and clinical characteristics in 670 patients. Medicine (Baltimore) 85:95–104

    Article  Google Scholar 

  25. Ratzinger G, Zelger BG, Carlson JA et al (2015) Vasculitic wheel—an algorithmic approach to cutaneous vasculitides. J Dtsch Dermatol Ges 11:1092–1117

    Google Scholar 

  26. Ratzinger G, Zelger BG, Zelger BW (2019) Bar code reader—an algorithmic approach to cutaneous occluding vasculopathies? Part II: medium vessel vasculopathies. J Dtsch Dermatol Ges 17:1115–1128

    PubMed  PubMed Central  Google Scholar 

  27. Ratzinger G, Zelger BG, Zelger BW (2019) Bar code reader—an algorithmic approach to cutaneous occluding vasculopathies? Part I: small vessel vasculopathies. J Dtsch Dermatol Ges 17:895–904

    PubMed  PubMed Central  Google Scholar 

  28. Reinhold-Keller E, Herlyn K, Wagner-Bastmeyer R, Gross WL (2005) Stable incidence of primary systemic vasculitides over five years: results from the German vasculitis register. Arthritis Rheum 53:93–99

    Article  Google Scholar 

  29. Requena L, Yus ES (2001) Panniculitis. Part I. Mostly septal panniculitis. J Am Acad Dermatol 45:163–183

    Article  CAS  Google Scholar 

  30. Rose C, Holl-Ulrich K (2017) Granulomatöses Reaktionsmuster in der Haut. Hautarzt 68:553–559

    Article  CAS  Google Scholar 

  31. Segura S, Pujol RM, Trindade F et al (2008) Vasculitis in erythema induratum of Bazin: a histopathologic study of 101 biopsy specimens from 86 patients. J Am Acad Dermatol 59:839–851

    Article  Google Scholar 

  32. Smolle J (2003) Prädilektionsstellen der Haut. J Dtsch Dermatol Ges 8:647–653

    Google Scholar 

  33. Sunderkötter CH, Zelger B, Chen KR et al (2018) Nomenclature of cutaneous vasculitis: dermatologic addendum to the 2012 revised international Chapel Hill consensus conference nomenclature of vasculitides. Arthritis Rheumatol 70:171–184

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to K. Holl-Ulrich.

Ethics declarations

Interessenkonflikt

K. Holl-Ulrich und C. Rose geben an, dass kein Interessenkonflikt besteht.

Für diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgeführt. Für die aufgeführten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Holl-Ulrich, K., Rose, C. Kutane Vaskulitis und Vaskulopathie. Pathologe 41, 355–363 (2020). https://doi.org/10.1007/s00292-020-00786-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00292-020-00786-9

Schlüsselwörter

Keywords

Navigation